These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19853188)

  • 1. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change.
    Franco EL; Mahmud SM; Tota J; Ferenczy A; Coutlée F
    Arch Med Res; 2009 Aug; 40(6):478-85. PubMed ID: 19853188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
    Franco EL; Cuzick J; Hildesheim A; de Sanjosé S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination.
    Franco EL; Ferenczy A
    Future Oncol; 2007 Jun; 3(3):319-27. PubMed ID: 17547527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus in cervical screening and vaccination.
    Crosbie EJ; Kitchener HC
    Clin Sci (Lond); 2006 May; 110(5):543-52. PubMed ID: 16597323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M
    Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS).
    Eltoum IA; Roberson J
    Cancer; 2007 Feb; 111(1):34-40. PubMed ID: 17262799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus testing for primary screening of cervical cancer precursors.
    Ratnam S; Franco EL; Ferenczy A
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Integrating HPV testing for primary screening?].
    Riethmuller D; Ramanah R; Pretet JL; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.